Indian Firm Panacea Says Aiming To Make Covid-19 Vaccine
Follow The Hawk on Google News+ FollowAdvertisement
Bengaluru: Indian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for Covid-19.
The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges. Panacea's shares jumped 20 per cent in morning trading on India's National Stock Exchange after the news.
Also readFSSAI to initiate action against Bisleri over unsafe water sampleGet The Hawk first on Google
Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.
Advertisement








